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We have identified and characterized a human endogenous retrovirus (HERV) gag transcript in the human pre-B cell
leukemia line Reh. The transcript was found to be a splice product of a structurally intact HERV element located on
chromosome 6q13. Its primer binding site is complementary to phenylalanine (F) tRNA, common for the HERV-F family, but
the overall genome sequence is closely related to the HERV-H family. The retroviral sequence was therefore designated
HERV-H/F. The HERV element shows a distinct mRNA expression pattern among hematopoietic cancer cell lines with
expression in some leukemia-derived cell lines of B-lymphoid and myeloid origin. No expression was observed in normal
human tissues, indicating a cancer-specific expression pattern. The 5 long terminal repeat (LTR) was tested for promoter
activity in HERV-H/F expressing and nonexpressing cell lines. The cell specificity of the LTR-mediated reporter gene
expression did not conclusively correlate with endogenous virus expression, indicating that the transcription regulation ofINTRODUCTION
Human endogenous retroviruses (HERVs) occupy about
7% of the human genome (Bock and Stoye, 2000) and are
very likely footprints of ancient germ cell retroviral infec-
tions by exogenous retroviruses that became fixed in the
species. Most HERV families entered the genome early in
the evolution of primates and were amplified before homi-
noids separated from Old World monkeys, i.e., 30–45 M
years ago (for a review see: Sverdlov, 2000). Today, these
sequences constitute an integral part of the human ge-
nome and are inherited in a mendelian fashion. However,
polymorphism in sequence and chromosomal distribution
of some HERVs does exist among the human population
(Turner et al., 2001). Phylogenetic and sequence analysis of
retroviral elements in the human genome have shown that
recombination events between different HERV families may
have played a role during the evolution of the human ge-
nome (Hughes and Coffin, 2001). At least 22 distinct HERV
families have been reported (Tristem, 2000). They are clas-
sified by their homology to animal retroviruses and are
often subdivided by the degree of pol homology or by the
primer-binding site (PBS) defining the tRNA species used
for priming reverse transcription, i.e., HERV-H utilizing
tRNAHis or HERV-W utilizing tRNATrp. The different HERV
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164families reside in the genome in varying copy numbers,
ranging from single (HERV-R) to 103–104 (HERV-H) copies
per genome (Lower et al., 1996). In addition, there is an
even higher number of solitary long terminal repeats (LTRs),
products of homologous recombination between the two
flanking LTRs of the provirus. Although most of the HERVs
are defective due to mutational decay, many of them are
transcriptionally active and some HERVs still contain open
reading frames (ORFs) for retroviral proteins. There are
examples of distinct HERV translation products with poten-
tially important biological functions. HERV-W ENV/syncytin
has been implicated in mediation of cell–cell fusion under
placental morphogenesis (Blond et al., 2000; Mi et al., 2000)
and HERV-K-encoded proteins in complementation of ex-
ogenous retroviral proteins like cORF (Magin et al., 1999)
and protease (Towler et al., 1998). Expression of potentially
immunosuppressive protein-encoding HERV-H env tran-
scripts has been detected in various normal and malignant
cell types (Lindeskog et al., 1999) and recently, full-length
envelope proteins have been shown to have immunosup-
pressive function in vivo (Mangeney et al., 2001). It was
shown that expression of the envelope protein of HERV-H in
normally rejected tumor cells allows immune escape and
proliferation in grafted mice. Other reports have shown that
HERV (HERV-K18 env)-encoded superantigen (SAg) expres-
sion is activated under special conditions such as after EBV
infection (Stauffer et al., 2001) or IFN- stimulation (Sut-
kowski et al., 2001).this gene is not alone dependent on cell-specific activity o
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Expression of mRNAs of distinct HERV families has
been shown to correlate with several pathologies (ter-f transc
; expre
atocarcinomas, tumor cell lines, inflammatory brain dis-
eases, autoimmunity (for review see Urnovitz and Mur-
phy, 1996; Lower, 1999), but also expression in normal
tissues has been reported (placenta, peripheral blood
mononuclear cells) (for review see Lower et al., 1996). In
general, HERV expression is controlled by specific reg-
ulatory sequence elements located mainly in the U3
region of the LTR (Schon et al., 2001; Majors, 1990). The
LTR provides signals required for transcription initiation
and termination, such as transcription factor binding
sites, enhancer elements, and polyadenylation signals.
Therefore it is possible that some of the solitary LTRs
have been adapted as regulatory elements of both sense
and antisense transcripts of adjacent genes (Brosius,
1999; Ling et al., 2001).
In this study, we have characterized a novel HERV
element, HERV-H/F. This HERV element shows a distinct
mRNA expression pattern among hematopoietic cancer
cell lines, whereas no expression was found in normal
tissues. Here we present and discuss its sequence,
phylogeny, expression, and LTR promoter activity.
RESULTS AND DISCUSSION
Characterization of a HERV transcript and provirus
assembly
A 393 nucleotides (nt)-long cDNA fragment was ini-
tially identified by comparing the transcriptome of the
human pre-B cell leukemia line Reh with that of the
Burkitt lymphoma cell line Bjab by means of cDNA
Representational Difference Analysis (Odeberg et al.,
2000). For further characterization, a polyadenylated
2238-nt-long cDNA was screened out of a Reh cDNA
library using the 393-nt-long cDNA fragment as a probe.
Sequence analysis (Accession No. AJ431196) revealed
close relationship to the gag gene of HERVs of the
HERV-H family (approximately 70% homology to human
RGH2) (Hirose et al., 1993). The 5 part of the sequence
contains a partial LTR region followed by a PBS with the
sequence 5-TGGTGCCGAAAGCCCGGGAT-3 almost com-
pletely complementary to the final 19 nt of human placenta
phenylalanine (F) tRNA (5-m1AUCCCGGG-UUUCGG-
CACCA-3) (Roe et al., 1975). The gag sequence is dis-
rupted by several frameshift mutations. A putative ORF,
from nucleotide 227 (ATG) to nucleotide 526 (TAA) in the
cDNA sequence encodes a 99 amino acid-long peptide
with no homologies to any characterized proteins. The
ATG initiation codon is embedded in the context CT-
GTCTAUGG with about 50% homology to the Kozak con-
sensus sequences GCCACCAUGG (Kozak, 1984) and
was predicted as start codon by the NetStart1.0 soft-
ware (Pedersen and Nielsen, 1997; http://www.cbs.dtu.dk/
services/NetStart). In vitro transcription and translation of
the cDNA gave no translation product (data not shown),
and therefore we cannot state that this open reading
frame is translated in cells.
A genomic Southern blot was hybridized under strin-
gent conditions with a probe derived from the gag se-
quence. The results show hybridization to a single band,
indicating a single copy of this HERV in the human
genome (Fig. 1A). BLAST analysis of annotated human
genome sequences revealed a cosmid with Accession
No. AC058818 (mapped to chromosome 6q13) to contain
the corresponding genomic sequence of our transcript
(Fig. 1B). The transcript appeared as a splice product of
a not yet described endogenous retroviral element. Sup-
ported by the cDNA sequence, we assembled the retro-
viral element with contigs 2 and 4 of cosmid AC058818,
where contig 2 is lacking the 5 LTR and the very begin-
ning of the gag gene, but contains the start of the pol
gene, and contig 4 includes the rest of the pol gene and
the complete env gene followed by a 3 LTR with a typical
TG . . . CA structure (Temin, 1981). The 3 LTR is preceded
by a putative polypurine tract. We therefore assumed to
have identified a structurally intact provirus (5 LTR-gag-
pol-env-3 LTR; Fig. 1B), even though the available
genomic sequence did not include the 5 LTR. Primers
were designed to amplify the 5 LTR to confirm its exis-
tence in genomic DNA. A 489-nt-long fragment was am-
plified from genomic DNA isolated from the Reh cell line
using a 5 primer identical to the first 18 nt of the 3 LTR
and a 3 primer complementary to the first 18 nt following
the retroviral PBS of the gag transcript. The PCR product
was cloned and five independent clones were se-
quenced. All sequences were identical to each other and
contained the first 126 nt of the originally isolated gag
transcript, confirming its association with the provirus, in
addition to a LTR sequence (Accession No. AJ431197)
homologous to the 3 LTR (90%, Fig. 2). The complete
assembled sequence of the retroviral element is about 8
kb long and displays a structurally intact provirus. A
schematic alignment of the genomic structure of the
provirus and the isolated related transcripts as well as
annotated expressed sequence tag (EST) sequences is
depicted in Fig. 1B.
Phylogenetic aspects of the HERV element
As stated above, the primer binding site of this HERV
is complementary to phenylalanine-tRNA (tRNAF), in
common with the HERV-F (Kjellman et al., 1999b),
HERV-Fb (Tristem, 2000), and HERV-XA34 (Kjellman et al.,
1999a) families and elements enclosed by LTR46 (unpub-
lished observation). But strikingly, the identified HERV
sequence is more related to the HERV-H family showing
approximately 70% nt identity in the gag gene region,
75% nt identity in pol and env gene regions, and 86% in
the R region of the LTR. Phylogenetic analysis of the pol
gene shows low relationship of the novel HERV to the
other HERV-F family members, but places it into a cluster
belonging to the HERV-H family. Interestingly, this cluster
is made up by a subfamily of ancient HERV-H family
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members located within Accessions Nos. AC004510,
AC002384, U95626, and AL354751 with 94.4, 93.9, 91.6,
and 91.9% identity, respectively, to 5 and 3 LTR (unpub-
lished elements found in indicated GenBank entries). All
these elements share similar integration dates and phe-
nylalanine tRNA PBSs (Fig. 3). We therefore suggest that
the novel HERV element be designated HERV-H/F. The
HERV-H/F cluster also includes sequences (AC002384,
AL354751, and HERV-H/F) with full-length gag genes, in
contrast to the HERV-H elements like RGH2, which bear
large deletions in this region. The phylogenetic analysis
may indicate a PBS shift inside the HERV-H “superfamily,”
a phenomenon reported for the murine retrovirus like
VL30 family (Itin and Keshet, 1985).
The env gene encompasses a region (Accession No.
AC058818, contig 4 nt 11660–11610) coding for a sequence
(LQNRQGLDLLTADKGGL) highly homologous to the immu-
nosuppressive peptide found in HERV-H19 (LQNRRGCDLL-
TAEKGGL) and other retroviruses (Lindeskog et al., 1999).
Although no ORF exists in frame with the immunosuppres-
sive env region, one cannot exclude the possibility that a
homologous peptide may be synthesized by mutational or
translational1 frameshifting in an A-rich region in the env
gene, thus promoting the synthesis of 25-kDa protein. How-
ever, this possibility remains speculative as long as no
further experimental evidence is presented.
The 5 LTR (446 bp; Accession No. AJ431197) and the
3 LTR (449 bp; Accession No. AC058818, contig 4 nt
11107–10659) of HERV-H/F share about 90% nucleotide
identity (402 identities shared on 446 nt; Fig. 2). Assum-
ing an average mutation rate of 0.13% per million years
(Sverdlov, 2000), the integration date of the virus may be
estimated to 35–40 M years ago, that is, before the
hominoid lineage diverged from the Old World apes (ap-
prox. 30 M years). As presented in Fig. 1A, the complete
HERV element is present in a single copy. Homology
searches with the 5 LTR sequence against the Human
Genome Sequence Database revealed at least 12
closely related LTRs distributed on chromosomes 1, 4, 6,
8, 9, 13, and X (Table 1). The relationship is outlined by
the alignment in Fig. 4. Three of the homologous solitary
LTRs are located in antisense direction in introns of
annotated genes (Table 1). Whether their presence af-
fects regulation of these genes remains unknown.
In conclusion, due to the closer relationship to the
HERV-H family of endogenous retroviruses and the pres-
ence of a tRNAPhe primer binding site, we suggest that the
novel HERV element identified on chromosome 6 be des-
ignated HERV-H/F.
HERV-H/F mRNA expression analysis
Following the initial observation of expression in the
pre-B leukemia cell line Reh, Northern blot analysis on
selected cancer cell lines of hematopoietic origin was
performed. Hybridization with the isolated cDNA, consti-
FIG. 1. Genomic Southern blot, sequence assembly and splice pattern. (A) Southern blot analysis with a 393-nt gag probe hybridized to fragmented
genomic DNA from human pre-B leukemia cell line Reh (HERV-H/F-expressing) and promyeloid leukemia cell line HL-60 (-nonexpressing). (B)
Schematic presentation of the assembled HERV-H/F sequence and alignment of the isolated gag mRNA and reported GenBank entries. Splice donor
(SD) and acceptor (SA) sites are indicated. Slashes indicate gaps of unknown length.
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tuting a gag specific probe, showed expression in only
five cell lines: in the two B-lymphoid cell lines Reh and
Nalm-6, both derived from acute lymphoblastic leukemia
(ALL), and in the three promyeloid cell lines KG1A, K562,
and U937 (Fig. 5). No expression could be detected in
two other B-cell leukemia lines (Tom-1 and BV173), in
three B-lymphoma cell lines (Daudi, Bjab, and U266), in
the myeloid leukemia cell line HL-60, or in any of the
three T-lymphoid leukemia cell lines (HPB-ALL, JM, Jur-
kat). Northern blot analysis of poly(A) mRNA reflecting
24 normal human tissues showed no hybridization signal
(data not shown). Three hybridizing transcripts are ob-
served with the gag probe, most probably reflecting the
full-length transcript (about 8 kb) and two splice products
located between 18S and 28S rRNA (Fig. 5). Hybridization
with a PCR-amplified 1557 nt probe specific for the env
gene (see Material and Methods) showed an expression
pattern similar to that shown for the gag probe (Fig. 5),
further supporting the sequence assembly of contigs 2
and 4 from cosmid AC058818. The alignment of identical
EST sequences with the HERV-H/F provirus also identi-
fied several splice variants which may be divided into
two classes by their 5 splice donor site (Fig. 1B). The
identified polyadenylated gag transcript with spliced out
pol and env genes as a GT-AG intron defines the first
class, whereas the second class uses a noncanonical
splice site to remove AA-AG introns from the pre-mRNA/
proviral transcript. The noncanonical splice donor is lo-
cated in the leader region between 5 LTR and gag, as
typically seen in mammalian type C exogenous retrovi-
ruses. Three alternative splice acceptor sites could be
identified in reported GenBank EST entries, located in
the 3 region of the gag gene (Accession No. BC021996),
at the 3 region of the pol gene (Accession No.
BG496877), and close to the polypurine tract in front of
the 3 LTR (Accession No. BF131466).
Interestingly, the 3 splice acceptor site in the pol gene
locates 129 nucleotides upstream relative to the TGG
FIG. 2. LTR analysis. Alignment of 5 and 3 LTR of the HERV-H/F element on chromosome 6. The LTRs share about 91% sequence identity.
Polypurine tract (PPT) and primer binding site (PBS) are indicated. Potential transcription factor binding sites as detected by MatInspector Release
Professional 5.2 (Quandt et al., 1995) are highlighted.
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codon of the first base of the conserved WTGS motif in
the C-terminal part of the integrase, which is similar to
the splice acceptor sites reported for other retroviruses.
The complex splice pattern found for the HERV-H/F ele-
ment appears similar to the alternative splice pattern of
the HERV-H family found in T-cell leukemia and normal
FIG. 3. Phylogenetic analysis. Unrooted tree of an alignment of a conserved sequence region of the HERV-H/F pol gene (Accession No. AC058818,
contig 2 nt 900–274).
TABLE 1
Identified HERV-H/F LTRs in the Available Human Genome Database
BAC clone Length (nt) Locus % Identity/% gaps Remarks
AC025699 461 1q43-44 83/5
AC024669 474 4p15 83/7 Located in intron of CALP (Unigene: Hs.193323)
AC080031 466 4q21.1-3 85/8
Z84476 471 6p21-22 85/7
HERV-H/F 5 LTR 446 6q13
AC058818 (HERV-H/F 3 LTR) 449 6q13 88/5
AC022058 471 8 84/7
AP002906 454 8q22-23 84/6 Located in intron of LC27 (Unigene: Hs.296398)
AL353753a 458 9p13 84/7 5 and 3 LTR of 5409-nt-long HERV-H/F homolog
AL353753b 459 9p13 84/6
AL354751 468 9p22 84/6 Located in intron of SPTLC1 (Unigene: Hs.90458)
AL354852 471 13 84/7
AL390875 454 Xq25-26 85/6
Note. LTRs are listed by their representing BAC clone. Homology of the respective LTRs to the HERV-H/F 5LTR reported in this study is indicated
by the percentage of identity and gaps as determined by Clustal W1.81.
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FIG. 4. Alignment of LTR homologues identified by homology searches against human genome database. LTRs are entitled by their presenting
cosmid (see Table 2); 5 and 3 LTRs of the full-length HERV-H/F element are marked HERV-H/F5 and AC058818*, respectively.
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leukocytes (Lindeskog and Blomberg, 1997), supporting the
idea of a regulatory function of alternative splicing in these
ancient infectious progenitors as found in HERV (Lower et
al., 1993) and in other retrovirus genera like lentiviruses,
HTLV-like viruses, and spumaviruses (Rabson and Graves,
1997). These findings support the mRNA expression data
showing hybridization to several transcripts with both gag
and env probes. None of the concomitant human EST
database GenBank entries are derived from normal human
tissues, but all were isolated from cancer cell lines derived
from various tissues (Table 2). The distinct expression pat-
tern among hematopoietic cancer cell lines and reported
GenBank entries suggests a cancer-specific expression of
our reported HERV-H/F transcripts.
All expression pattern data presented here are based on
Northern blot analyses and all HERV-H/F-expressing leuke-
mia cell lines are reflecting early stages of B and myeloid
lineage differentiation taking place in the bone marrow. We
cannot rule out the possibility that HERV-H/F is expressed
in normal cells of these differentiation stages, since these
are present only in low numbers in normal human bone
marrow or peripheral blood leukocytes. Nonetheless, both
the HERV-H/F-expressing cell line Reh and the nonexpress-
ing cell line HL-60 show a single band of identical size in
the genomic Southern blot (Fig. 1A), indicating that the cell
specificity of HERV-H/F gene expression is a result of gene
regulation rather than gene amplification.
5 LTR promoter activity
To further characterize the regulation of HERV-H/F
transcription, its 5 LTR was analyzed for potential tran-
FIG. 5. HERV-H/F mRNA expression. Hybridization with probes specific for gag and env of HERV-H/F against total RNA from selected human
hematopoietic cancer cell lines (B-lineage: Reh, BV173, Nalm-6, Tom-1, Daudi, Bjab, U266; T-lineage: HPB-ALL, JM, Jurkat; myeloid lineage: KG1A,
HL-60, K562, U937, and the cervix carcinoma cell line HeLa).
TABLE 2
Selected HERV-H/F GenBank Human EST Database Entries
Human tissue library Mammalian
gene collection (MGC) Tissue Cancer cell line origin Genbank Accession No.
NIH_MGC60 Prostate Adenocarcinoma BG500808, BG498497
NIH_MGC91 Prostate Adenocarcinoma BG284793, BG283193
NIH_MGC59 Lung Mucoepidermoid carcinoma BG496877, BG776076
NIH_MGC55 Bone marrow Acute myeloid leukemia BF243442, BE748890
NIH_MGC54 Bone marrow Chronic myeloid leukemia BC021996, BF211467
NIH_MGC72 Skin Melanotic melanoma BE891699
NIH_MGC58 Kidney Hypernephroma BF131466
NIH_MGC61 Testis Embryonal carcinoma BG529567
Note. Human ESTs identical to the reported HERV-H/F sequence on 6q13 are all derived from cell line cDNA libraries of the Mammalian gene
collection (http://mgc.nci.nih.gov/). Origin of representative GenBank EST entries are indicated.
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scription factor binding sites and tested for promoter
activity in a reporter gene assay. Many of the predicted
potential transcription factor binding sites found in the 5
LTR of HERV-H/F are related to transcription factors
(GATA-1, vMYB, AML1, PBX1, ETS-1, ELK-1; Fig. 2) in-
volved in normal hematopoiesis and with aberrant ex-
pression in B and myeloid lineage leukemia (Crans and
Sakamoto, 2001).
The LTR with its adjacent primer binding site was
cloned in front of the gene encoding green fluorescent
protein (EGFP) and transiently transfected into the hu-
man cancer cell lines Reh, Bjab, Jurkat, and K562. The
reporter gene activity was evaluated by flow cytometric
analysis of EGFP expression in living cells (Fig. 6). Al-
though this reporter gene assay does not allow a quan-
titative analysis of promoter activity, its sensitivity is ad-
equate to receive a qualitative result. In order to evaluate
the promoter activity of the LTR, a promoterless construct
(background) and constructs bearing EGFP under the
control of the CMV or the ephrin-A4 promoter were
tested in parallel. The expression of the receptor tyrosine
kinase ligand ephrin-A4 in the examined cell lines has
been reported earlier by our laboratory (Aasheim et al.,
2000) and its promoter has been characterized recently
(Munthe and Aasheim, submitted). Although gag tran-
scripts were detectable only in Reh and K562 cells, EGFP
expression, under the control of the 5 LTR, was ob-
served in Reh, K562, and Jurkat cells (Fig. 6). No EGFP
expression was detected in the gag-negative cell line
Bjab. The results indicate that the cell-specific expres-
sion of HERV-H/F may involve additional control mecha-
nisms and is not regulated only by cell-specific activity of
transcription factors. This may be achieved by repressor
elements binding outside the 5 LTR and/or by general
genomic silencing mechanism like modulation of chro-
matin structure, methylation, or acetylation.
Because of the cell type-specific expression of many
reported HERVs, gene therapy research has drawn at-
tention to the LTRs as versatile tools for the construction
of targeted retroviral expression vectors (Schon et al.,
2001). The LTR-mediated EGFP expression in Jurkat cells
emphasizes that the transfer of HERV LTRs into gene
therapeutic applications deserves special consideration.
Conclusions
The detection of a gag-related transcript in the human
leukemia cell line Reh led to the identification of a mem-
ber of a new HERV-H subfamily, designated HERV-H/F
and located on chromosome 6q13. Expression of un-
spliced and spliced subgenomic HERV-H/F mRNAs
could be detected only in B and myeloid lineage leuke-
mia cell lines trapped at early stages of differentiation,
but expression in other malignant cell lines has also
been reported. The expression may be cancer related
since no expression so far has been detected in normal
human tissues. The 5 LTR driving the transcription was
tested for promoter activity and the expression pattern of
HERV-H/F did not conclusively correspond to the pro-
moter activity in transfected cells. A biological signifi-
cance of the observed expression of HERV-H/F remains
unclear and lies beyond the scope of our presented
characterization.
MATERIAL AND METHODS
Cell culture
The following human cell lines were used in this study:
pro-B-cell lines Tom-1 (Okabe et al., 1987) and BV173
FIG. 6. LTR promoter activity. (A) LTR-mediated EGFP reporter gene expression in HERV-H/F-expressing (Reh, K562) and -nonexpressing cell lines
(Bjab, Jurkat). For comparison, EGFP expression of a promoterless (del(CMV)), CMV promoter, and ephrin-A4 promoter construct were tested in
parallel. Results shown are from a representative experiment of three. (B) The same cell lines were tested for endogenous HERV-H/F mRNA
expression by Northern blot analysis.
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(DSZM ACC20), pre-B-cell lines Reh (ATCC CRL 8286)
and Nalm 6; mature B-cell lines Bjab (Dr. G. Molden-
hauer, University of Heidelberg, Heidelberg, Germany)
and Daudi (ATCC CCL 213); plasmacytoid cell line U266
(ATCC TIB 196); T-cell lines JM (ECACC 86010201), Jurkat
(ATCC TIB 152), and HPB ALL (DSZM ACC 483); myeloid
cell lines KG1-A (ATCC CCL 246); HL-60 (ATCC CCL 240)
and U937 (ATCC CRL-1596); erythroid precursor cell line
K562 (ATCC CCL-243); and cervical carcinoma cell line
HeLa (ATCC CCL 2). All cell lines were grown in RPMI
1640 medium supplemented with 10% fetal bovine serum
and antibiotics at 37°C in a humidified atmosphere with
5% CO2.
RNA isolation and Northern blot analysis
Total RNA from cell lines was isolated by standard
methods (Chomczynski and Sacchi, 1987). For Northern
blot analysis 15 g total RNA was separated (1% agarose
gel) under denaturing conditions and transferred to Hy-
bond-N membrane (Amersham Biosciences Ltd., UK).
All hybridizations were performed at 65°C. Probes were
[32P]dCTP labeled using the rediprime II random prime
labeling system (Amersham Biosciences). Blots were
washed stringently, and hybridization was evaluated by
autoradiography using the Storm 860 PhosphorImaging
system (Amersham Biosciences). Commercially avail-
able Northern tissue blots were obtained from Clontech
(MTN I and I; Clontech, CA).
Genomic DNA isolation and Southern blot
hybridization
Genomic DNA was isolated from cell lines using the
QIAamp DNA blood mini kit (QIAGEN GmbH, Germany).
For Southern blotting 10 g of genomic DNA was di-
gested by incubation overnight at 37°C with the restric-
tion endonucleases PstI, HindIII, or EcoRI, respectively,
using the supplied buffer solutions in presence of 4 mM
spermidine. DNA digests were separated overnight on
an 0.8% agarose gel and blotted to Hybond N mem-
brane (Amersham Biosciences). Probe labeling and hy-
bridization were performed as described for Northern
blot analysis.
First-strand cDNA synthesis and PCR
Poly(A) mRNA was isolated from total RNA using
oligo(dT) beads, and first-strand cDNA was synthesized
directly on mRNA bound to oligo(dT), as described pre-
viously (Aasheim et al., 1994). Finally the first-strand
cDNA beads were washed twice in 100 l TE buffer,
solved in 25 l TE, and stored at 20°C. All PCR reac-
tions were performed under the following final condi-
tions: 10 mM Tris–Cl, pH 8.3, 1.5 mM MgCl2, 50 mM KCl
(adjusted with 10 buffer); 0.16 mM dNTP (Amersham
Biosciences); 0.02 U/l Taq polymerase; 0.1 M each
primer). The 393-nt gag probe was PCR amplified from
the isolated gag cDNA (Accession No. AJ431196) clone
using the primers 5-TTGTGGGACTTAGACAACTTC-3
(forward) and 5-TTTGGTTCCTGCCACCTCTC-3 (reverse).
The 1547-nt env probe was PCR amplified from 1 l cDNA
from KG1A cells in a 50-l reaction using the forward
primer 5-CAATCCTTCCTATGCATTTCC-3 and the reverse
primer 5-CTAAGCTAGAGAATGGCCAGG-3, resulting in a
single PCR product. The 5 LTR was PCR amplified from 2
g genomic DNA from Reh cells using forward primer
5-TGTAAGGTCCTCTGAGCA-3 and reverse primer 5-
GTCTGCCGGAGGAGTTCC-3. The PCR product was sub-
cloned into pGEM-T Easy Vector System (Promega Corp.)
AseI and XhoI endonuclease restriction sites at the ends of
the LTR for directional cloning into the pEGFP-N3 vector
were introduced by PCR on this clones using primers 5-
CCCATTAATTGTAAGGTCCTCTGAGCA-3 and 5-CCCCTC-
GAGGTCTGCCGGAGGAGTTCC-3.
Green fluorescence protein (EGFP) reporter gene
assay
For analysis of promoter activity, the CMV promoter of
the EGFP gene in the pEGFP-N3 vector (Clontech Labo-
ratories) was removed using the restriction endonucle-
ases AseI and XhoI (New England Biolabs, Inc.) and
replaced by either the HERV-H/F 5 LTR or the ephrinA4
promoter. As background control, promoterless pEGFP-
N3 vector was constructed by filling in overhang with
Klenow polymerase and religation of the blunt-ended
vector. Transient transfection of cells was performed by
electroporation. Exponentially growing cells (0.5–1 106/
ml) were harvested and resuspended in RPMI 1640 and
kept on ice; 5 g of the different promoter constructs was
added to 400-l cells (1–2 106/ml). Electroporation was
conducted at 200 V for 70 ms (Reh, Jurkat), 30 ms (K562),
and 10 ms (BJAB), respectively, using an ECM 830 Electro
Square Porator (BTX, Inc., San Diego, CA). After electro-
poration, 800 l of conditioned medium supplemented
with 5% FBS was added immediately, and the cells were
incubated at 37°C overnight. EGFP expression was mon-
itored by FACS analysis of 2  104 living cells.
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